Pharmapack 2021: Pre-filled syringe technology could provide answers to future mass vaccination challenges, says BD
Pre-filled syringes (PFS) could help immensely in solving the challenges of rolling out future mass vaccination campaigns, according to experts at Becton Dickinson (BD).
Speaking at the Pharmapack Europe 2021 online conference in the session Responding to the Vaccine Delivery Challenges, Marie-Liesse Le Crofec, Global Portfolio Marketing Head, BD said that depending on the specificities of vaccines and their intended use situations, PFS technology could increase efficiency of workflow, increase dose-sparing capabilities compared to vials and have potential to limit random waste volume.
“It’s important that all stakeholders understand the benefits in terms of patient safety of PFS but also efficiency,” she said.
Quoting a 2010 study in the Expert Review of Vaccines, she said that it was calculated on the occasion of the last flu pandemic that the use of PFS to vaccinate 300 million people in the US could save over 3 million hours in healthcare worker time.
“The corresponding savings could contribute to making the decision of using PFS instead of multidose vials and disposable syringes cost neutral,” she added.
In terms of addressing current mass vaccination delivery challenges, Ms Le Crofec, said it made more sense to use existing vaccine distribution and administration infrastructures instead of creating new systems from scratch.
“We’ve witnessed that whenever the regular healthcare providers, the regular channels that are used to vaccinate against flu such as nursing homes and employers, were used, things were much smoother in the supply chain,” she explained.
She said another practical recommendation for government and authorities’ taskforces, was to ensure that experts with knowledge of all aspects of planning relative to pandemic response such as pharmacists and supply chain specialists are added to those teams.
“In the real-life clinical environment, before the purchase of massive amounts and release for use in vaccine administration, there were cases when sometimes we were asked for needles that clearly were not the appropriate length for those types of vaccines,” she said. “Having the right experts and practical testing of the disposable syringes that are used in such campaigns is what we really recommend for the future of this vaccination campaign and for future mass vaccination programmes.”
Guillaume Lehée, R&D Innovation Leader, BD said several drug formulations and technologies such as RNA vaccines and cell and gene therapies may require storage to very low negative temperatures such as -20 to -196 C.
He said that while the compatibility of vial containers with frozen storage conditions has quite a long and significant history, in contrast PFS compatibility has been quite poorly documented, with the main example of a glass PFS approved for cold storage being Medimmune’s Fluenz Tetra Nasal flu vaccine with a 20-week shelf life at -25 C.
He said that testing done by BD had shown that glass PFS did not present any risk regarding ensuring key product functions and sub-visible particles performance and maintaining container closure integrity during the thermal cycle when stored one week at -20 C and even down to -40 C.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance